UnknownNot Applicable

Non-penetrating Deep Sclerectomy Versus Trabeculotomy- Trabeculectomy Operation in Treatment of Primary Congenital Glaucoma

Egypt40 participantsStarted 2022-02-01

Plain-language summary

The high success rate of the non-penetrating deep sclerectomy (NPDS) procedure in adult glaucomatous patients motivated some glaucoma specialists to try it as an alternative procedure in childhood PCG. In deep sclerectomy, the surgeon fashions a partial-thickness scleral flap and excises the outer parts of both Schlemm's canal and trabecular meshwork without opening the eye, leaving a thin trabeculo-descemetic membrane. This membrane will guard against early postoperative hypotony due to the non-penetrating nature of the procedure. The aim of this study is to assess the safety and efficacy outcomes of non-penetrating deep sclerectomy versus combined trabeculotomy-trabeculectomy in the treatment of congenital primary glaucoma

Who can participate

Age range1 Year – 20 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patients with PCG younger than 6 years old with a HCD between 12-14 mm ware Exclusion Criteria: * patients with anterior segment anomalies, * secondary glaucoma * previous anterior segment surgeries * patients more than 6 years old

What they're measuring

Intra Occular Pressure

Timeframe: Base line

Intra Occular Pressure

Timeframe: Post 1 week

Intra Occular Pressure

Timeframe: Post 1 month

Intra Occular Pressure

Timeframe: Post 3 month

Intra Occular Pressure

Timeframe: Post 6 month

Trial details

NCT IDNCT06189326

SponsorAl-Azhar University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-12-01

View on ClinicalTrials.gov More Congenital Glaucoma trials